http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022044579-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dbdfa36b677f4ef61245ca725011e221 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
| filingDate | 2021-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1025c12175d15ec668f1e4e78a10f842 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e656ff11f43b426382ae4cca1b5740fb |
| publicationDate | 2022-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2022044579-A |
| titleOfInvention | Eye drops |
| abstract | PROBLEM TO BE SOLVED: To provide an eye drop having low irritation. SOLUTION: The eye drop contains a hyaluronic acid derivative having a steryl group introduced therein. The hyaluronic acid derivative into which the steryl group has been introduced may have a repeating unit represented by the general formula (I). The R may be a cholesteryl group. The eye drops may further contain a pharmacologically active ingredient. The eye drops may further contain a pharmaceutically acceptable additive. [Chemical 1] [Selection diagram] None |
| priorityDate | 2020-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 362.